Investing IdeasBrowse All StocksMarkets

Have your own idea? Try our Stock Screener

Header cover image

U.K. (FTSE) Pharma Industry Analysis

UpdatedApr 14, 2025
DataAggregated Company Financials
Companies17
  • 7D-0.2%
  • 3M-3.8%
  • 1Y-9.5%
  • YTDn/a

Over the last 7 days, the Pharma industry has dropped 6.9%, driven by a pullback from AstraZeneca of 7.4%. In contrast, Sareum Holdings has gained 17%. However, the industry is down 9.7% over the past year. Looking forward, earnings are forecast to grow by 15% annually.

Industry Valuation and Performance

Has the U.K. Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 14 Apr 2025UK£247.9bUK£87.2bUK£9.7b28.8x25.7x2.8x
Wed, 12 Mar 2025UK£283.5bUK£87.7bUK£9.6b28.9x29.5x3.2x
Fri, 07 Feb 2025UK£285.3bUK£87.1bUK£9.1b31.7x31.3x3.3x
Sun, 05 Jan 2025UK£226.4bUK£75.8bUK£7.8b31.4x28.9x3x
Tue, 03 Dec 2024UK£225.9bUK£75.1bUK£7.7b31.8x29.2x3x
Thu, 31 Oct 2024UK£238.7bUK£72.5bUK£9.1b30.5x26.3x3.3x
Sat, 28 Sep 2024UK£250.9bUK£71.3bUK£8.9b30.5x28.1x3.5x
Mon, 26 Aug 2024UK£275.7bUK£71.8bUK£8.9b41.6x30.8x3.8x
Wed, 24 Jul 2024UK£258.1bUK£70.9bUK£9.5b35.4x27.3x3.6x
Fri, 21 Jun 2024UK£266.0bUK£71.7bUK£9.6b30x27.8x3.7x
Sun, 19 May 2024UK£268.2bUK£71.5bUK£9.6b34.9x28x3.7x
Tue, 16 Apr 2024UK£247.5bUK£71.4bUK£9.8b33x25.3x3.5x
Thu, 14 Mar 2024UK£240.5bUK£70.2bUK£9.7b33.1x24.8x3.4x
Sat, 10 Feb 2024UK£225.8bUK£69.7bUK£9.6b34.8x23.5x3.2x
Mon, 08 Jan 2024UK£241.2bUK£68.9bUK£10.7b36x22.6x3.5x
Wed, 06 Dec 2023UK£227.5bUK£69.3bUK£10.7b34.3x21.2x3.3x
Fri, 03 Nov 2023UK£231.4bUK£70.9bUK£11.0b52.6x21x3.3x
Sun, 01 Oct 2023UK£247.2bUK£70.5bUK£10.4b76.3x23.8x3.5x
Tue, 29 Aug 2023UK£235.2bUK£69.4bUK£10.2b53.5x23x3.4x
Thu, 27 Jul 2023UK£235.9bUK£67.1bUK£7.8b52x30.2x3.5x
Sat, 24 Jun 2023UK£248.0bUK£67.8bUK£7.9b55.5x31.5x3.7x
Mon, 22 May 2023UK£257.1bUK£68.6bUK£8.0b56.6x32.3x3.7x
Wed, 19 Apr 2023UK£260.2bUK£69.3bUK£6.9b57.6x37.9x3.8x
Fri, 17 Mar 2023UK£235.2bUK£70.2bUK£6.9b44.3x33.9x3.3x
Sun, 12 Feb 2023UK£249.4bUK£70.4bUK£7.4b40.8x33.8x3.5x
Tue, 10 Jan 2023UK£252.5bUK£79.7bUK£6.3b39.2x40x3.2x
Thu, 08 Dec 2022UK£246.8bUK£79.8bUK£6.3b36.5x39x3.1x
Sat, 05 Nov 2022UK£235.4bUK£80.7bUK£3.7b20.1x64.1x2.9x
Mon, 03 Oct 2022UK£217.5bUK£81.3bUK£3.6b19.5x59.6x2.7x
Wed, 31 Aug 2022UK£238.9bUK£79.3bUK£3.7b14.1x64.1x3x
Fri, 29 Jul 2022UK£254.2bUK£75.1bUK£4.6b15.2x55.6x3.4x
Sun, 26 Jun 2022UK£268.8bUK£74.3bUK£4.6b16.8x58.8x3.6x
Tue, 24 May 2022UK£267.5bUK£73.5bUK£4.6b17.4x58.4x3.6x
Thu, 21 Apr 2022UK£265.5bUK£66.7bUK£4.8b20.1x55.3x4x
Price to Earnings Ratio

55.3x


Total Market Cap: UK£265.5bTotal Earnings: UK£4.8bTotal Revenue: UK£66.7bTotal Market Cap vs Earnings and Revenue0%0%0%
U.K. Pharma Industry Price to Earnings3Y Average 36.2x202320242025
Current Industry PE
  • Investors are pessimistic on the British Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 25.7x which is lower than its 3-year average PE of 36.2x.
  • The 3-year average PS ratio of 3.4x is higher than the industry's current PS ratio of 2.8x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 26% per year over the last three years.
  • Revenues for these companies have grown 9.3% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Comparison

How does U.K. Pharma compare with similar industries?

GB Market3.23%
Healthcare-0.12%
Pharma-0.18%
Pharma-0.18%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
HLN HaleonUK£3.755.0%
+UK£1.6b		15.7%PE23.4x
HCM HUTCHMED (China)UK£2.086.7%
+UK£113.3m		-27.5%PE62.8x
HIK Hikma PharmaceuticalsUK£18.302.0%
+UK£79.4m		1.3%PE14.7x
SAR Sareum HoldingsUK£0.1716.7%
+UK£3.3m		9.4%PB5.4x
ANCR Animalcare GroupUK£2.131.9%
+UK£2.8m		-3.2%PE31.8x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlans & PricingLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

N4P

UK£0.0037

N4 Pharma

7D

-11.8%

1Y

-55.9%

AZN

UK£100.08

AstraZeneca

7D

-0.5%

1Y

-9.2%

INC

UK£0.063

Incanthera

7D

-26.5%

1Y

-53.7%

FUM

UK£0.099

Futura Medical

7D

3.2%

1Y

-72.7%

NFX

UK£0.0011

Nuformix

7D

-9.1%

1Y

-46.3%

HLN

UK£3.75

Haleon

7D

5.0%

1Y

15.7%

Earnings Not Telling The Story For Haleon plc (LON:HLN)

Apr 09
Earnings Not Telling The Story For Haleon plc (LON:HLN)

HCM

UK£2.08

HUTCHMED (China)

7D

6.7%

1Y

-27.5%

HUTCHMED (China) Limited's (LON:HCM) Stock Retreats 25% But Earnings Haven't Escaped The Attention Of Investors

Apr 09
HUTCHMED (China) Limited's (LON:HCM) Stock Retreats 25% But Earnings Haven't Escaped The Attention Of Investors

HIK

UK£18.30

Hikma Pharmaceuticals

7D

2.0%

1Y

1.3%

Investors Appear Satisfied With Hikma Pharmaceuticals PLC's (LON:HIK) Prospects

Apr 08
Investors Appear Satisfied With Hikma Pharmaceuticals PLC's (LON:HIK) Prospects

AGY

UK£0.052

Allergy Therapeutics

7D

-14.6%

1Y

84.2%

GSK

UK£12.94

GSK

7D

-2.8%

1Y

-21.3%

INDV

UK£6.87

Indivior

7D

-4.2%

1Y

-56.3%

CEL

UK£0.065

Celadon Pharmaceuticals

7D

-7.1%

1Y

-94.0%

POLB

UK£0.027

Poolbeg Pharma

7D

12.5%

1Y

-72.9%

SAR

UK£0.17

Sareum Holdings

7D

16.7%

1Y

9.4%

ANA

UK£0.0045

Ananda Pharma

7D

5.9%

1Y

38.5%

ANCR

UK£2.13

Animalcare Group

7D

1.9%

1Y

-3.2%